MRN Launches PreDict Product Development Service Offering

Medical Research Networx, LLC launches PreDict Product Development Service offering. MRN will now offer scalable services ranging from the design and development of assays to commercially-ready laboratory developed tests (LDT) or FDA cleared kits under a complete Quality System. Through MRN’s commercial partners, MRN can offer FDA-audited cGMP facilities for contract manufacturing. MRN’s preferred clinical sites are CLIA/NYS accredited labs within leading university centers, within globally recognized centers of excellence. MRN PreDict services incorporate all product development phases and provide support as, when and where needed. Platforms can be manual or automated, and MRN works with protein, DNA/RNA and other bio-molecular targets. 

Dr. Jeffrey Allard, Senior VP of Clinical and Regulatory Affairs commented “this offering is a natural extension of the expertise and relationships that MRN has developed over the years.  Given our background as a provider to the IVD industry, and our expertise in the design, validation and commercialization of laboratory tests, this service is a natural fit for our business.”

For more information on MRNs comprehensive Product Development offerings, please visit the MRN website.

© 2018 Medical Research Networx